Journal profile · Pharmacology & Pharmacy
DARU-Journal of Pharmaceutical Sciences
ISSN 1560-8115 · eISSN 2008-2231 · Springer International Publishing · IRAN · Quarterly · Founded 2012
DARU-Journal of Pharmaceutical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.8; fully open access; APC about USD 4,590; median 148 days to acceptance (106 articles, last 24 months); community-reported acceptance: easy; 31 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
DARU-Journal of Pharmaceutical Sciences is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Drug Delivery Systems, Drug Solubulity and Delivery Systems and Advancements in Transdermal Drug Delivery, together about 25.1% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
DARU Journal of Pharmaceutical Sciences is a peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment. The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics10.3%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.7%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics7.1%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences6.3%
- Nanoparticle-Based Drug DeliveryMaterials Science5.9%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences5.4%
- Synthesis and biological activityChemistry4.8%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.8LetPub ·
- CiteScore 2026-06
- 4.8LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.65LetPub ·
- h-index
- 33LetPub ·
- h-index
- 70OpenAlex ·
- i10-index
- 612OpenAlex ·
- 2-year mean citedness
- 2.79OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 13.01%LetPub ·
Volume
- Articles per year
- 28LetPub ·
Articles by year OpenAlex count · 1,131 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 80 | 76 | 13 |
| 2025 | 31 | 29 | 66 |
| 2024 | 54 | 53 | 381 |
| 2023 | 44 | 44 | 324 |
| 2022 | 32 | 32 | 469 |
| 2021 | 47 | 47 | 768 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
148 daysMedian, submission to acceptance · P25–P75 101 days – 184 days
- Acceptance to online
- median 21 days (106 articles)
- Submission to online
- median 166 days
- Sample
- 106 articles with submission and acceptance dates (150 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Not considered
- manusciipt
Article types accepted9, with length limits
- case reportOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…main text ≤ 1,500 words
- editorialOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…main text ≤ 1,500 words
- editorial and letter to the editorEditorial and Letter to the Editor (maximum: 1500 words excluding abstract, references and tables, maximum number of references: 10, maximum number of tables an…Length not stated
- letter to the editorOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…Length not stated
- meta-analysisOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…Length not stated
- original researchOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…Length not stated
- reviewOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…main text ≤ 5,000 words
- short communicationOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…main text ≤ 2,500 words
- systematic reviewOriginal Research (maximum: 5000 words excluding abstract, references and tables, maximum number of references: 80, maximum number of tables and figures: 10) Ab…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review
- AI use Generative AI Images
LLMs do not satisfy authorship criteria; AI-assisted copy editing need not be declared Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statement required for original research Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in DARU Journal of Pharmaceutical Sciences, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Double anonymous peer review (SNAPP) Model summary
SNAPP Double Anonymous Peer Review Guidelines
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- IRAN
- Language
- English
- Frequency
- Quarterly
- Founded
- 2012
- ISSN
- 1560-8115
- Electronic ISSN
- 2008-2231
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about DARU-Journal of Pharmaceutical Sciences
What CAS zone is DARU-Journal of Pharmaceutical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, DARU-Journal of Pharmaceutical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of DARU-Journal of Pharmaceutical Sciences?
The latest impact factor listed by LetPub is 2.8; CiteScore 4.8, h-index 70.
How long does peer review take at DARU-Journal of Pharmaceutical Sciences?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 148 days (interquartile range 101–184 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of DARU-Journal of Pharmaceutical Sciences?
According to the journal's author guidelines: Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index DARU-Journal of Pharmaceutical Sciences?
According to LetPub and DOAJ records, DARU-Journal of Pharmaceutical Sciences is indexed in SCIE and Scopus.
Is DARU-Journal of Pharmaceutical Sciences open access, and what is the APC?
DARU-Journal of Pharmaceutical Sciences is a fully open-access journal. APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .